ETAGX (ETAGX) Stock Price & Analysis
ETAGX (ETAGX) fell 1.47% to USD 60.85 as of July 26, 2026 at 02:23 UTC, according to Nexqual real-time market data.
ETAGX last closed at USD 61.76; the session ranged USD 60.85–60.85 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 48.37–66.38 (NAS). Source: Nexqual, July 26, 2026 at 02:23 UTC.
Key Statistics (as of July 26, 2026 at 02:23 UTC)
| Price | USD 60.85 |
|---|---|
| Change | ▼ 1.47% (down) |
| Previous Close | USD 61.76 |
| Open | USD 60.85 |
| Day Range | USD 60.85 – 60.85 |
| 52-Week Range | USD 48.37 – 66.38 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (ETAGX)
Nexqual's technical model rates ETAGX "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 02:23 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.29 (neutral) |
| vs SMA50 | Below (USD 62.03) |
| MACD | -0.13 (negative) |
Financial Health Score (ETAGX)
Nexqual rates ETAGX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 02:23 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ETAHX | Eventide Healthcare & Life Scie | USD 53.7 | ▼ 0.5% |
| ETILX | Eventide Gilead Fund Institutio | USD 64.13 | ▼ 2.11% |
| ETGLX | Eventide Gilead Fund | USD 61.43 | ▼ 2.12% |
| ETCGX | Eventide Gilead Fund Class C | USD 51.12 | ▼ 2.11% |
| TLVAX | Timothy Plan Large/Mid Cap Valu | USD 23.73 | ▲ 0.98% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 02:23 UTC. This page is informational and not investment advice.